Page 79 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Initiated coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Initiated Coverage Today - Breaking & Trending Today

Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Tuesday. The firm issued a hold rating on the software maker’s stock. MDRX has been the subject of a number of other research reports. Barclays initiated coverage on Veradigm in a research note on Wednesday, January 3rd. […] ....

United States , New Zealand General , New Zealand , Wellington Management Group , Veradigm Inc , William Blair Investment Management , Deutsche Bank Aktiengesellschaft , Pacer Advisors Inc , Royal Bank , Kent Lake Capital , Free Report , Management Group , Blair Investment Management , Lake Capital , Creative Planning , Get Free Report , Veradigm Daily , Nasdaq Mdrx , Business Service , Initiated Coverage , Stocknews Com ,

Rosenblatt Securities Initiates Coverage on NICE (NASDAQ:NICE)

Rosenblatt Securities began coverage on shares of NICE (NASDAQ:NICE – Free Report) in a research note published on Tuesday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $285.00 target price on the technology company’s stock. Several other research firms have also issued reports on NICE. JMP Securities restated a market outperform […] ....

Company Profile , Partners Investment Advisory , Mcglone Suttner Wealth Management Inc , Lindbrook Capital , Rosenblatt Securities , Free Report , Marketbeat Ratings , Get Free Report , Glone Suttner Wealth Management , Street Partners Investment Advisory , Nasdaq Nice , Computer And Technology , Initiated Coverage ,

QUALCOMM (NASDAQ:QCOM) Earns Buy Rating from Analysts at Benchmark

Benchmark initiated coverage on shares of QUALCOMM (NASDAQ:QCOM – Free Report) in a research note issued to investors on Tuesday, MarketBeat reports. The brokerage issued a buy rating and a $200.00 price target on the wireless technology company’s stock. A number of other research analysts have also recently commented on QCOM. Piper Sandler upped their […] ....

Neil Martin , Piper Sandler , Cristianor Amon , Richardson Capital Management , Asset Management Corp , Securities Exchange Commission , Qualcomm Technology Licensing , Jpmorgan Chase Co , Dinuzzo Private Wealth Inc , Carsonallaria Wealth Management Ltd , Cherry Tree Wealth Management , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Management Corp , Allaria Wealth Management , Capital Management , Nuzzo Private Wealth , Tree Wealth Management , Qualcomm Strategic Initiatives , Nasdaq Qcom , Computer And Technology , Initiated Coverage , Benchmark Co ,

Rocky Mountain Chocolate Factory (NASDAQ:RMCF) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Rocky Mountain Chocolate Factory (NASDAQ:RMCF – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the stock. Rocky Mountain Chocolate Factory Stock Performance Shares of RMCF opened at $3.56 on Wednesday. Rocky Mountain Chocolate Factory has a 1 year […] ....

Jeffrey Richart Geygan , Leverty Financial Group , Mountain Chocolate Factory Inc , Global Value Investment Corp , Securities Exchange Commission , Retail Stores , Salvus Wealth Management , International Assets Investment Management , Rocky Mountain Chocolate Factory , Free Report , Global Value Investment , Exchange Commission , Director Jeffrey Richart Geygan , Financial Group , Wealth Management , Assets Investment Management , Get Free Report , Mountain Chocolate Factory , Rocky Mountain Chocolate Factory Daily , Nasdaq Rmcf , Retail Wholesale , Initiated Coverage , Stocknews Com ,

Capital One Financial Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)

Capital One Financial started coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $6.00 price objective on the biotechnology company’s stock. Capital One Financial also issued estimates for Heron Therapeutics’ Q1 2024 earnings at […] ....

Heron Therapeutics Company Profile , Richmond Brothers Inc , Needham Company , Orchard Capital Management , Heron Therapeutics Inc , Panagora Asset Management Inc , Capital One Financial , Heron Therapeutics , Free Report , One Financial , Get Free Report , Capital Management , Asset Management , Monaco Asset Management , Heron Therapeutics Daily , Nasdaq Hrtx , Initiated Coverage , Capital One Financial Co ,